Miles White

Latest Headlines

Latest Headlines

Post-pharma Abbott soars on Dx, struggles with devices

The new Abbott Laboratories is counting on med tech for revenue growth in a proprietary-drug-free future, and the company is so far succeeding in diagnostics while medical device sales falter.

Abbott CEO scores $25M, while new AbbVie chief nets $8M

Abbott Laboratories gives us a two-fer in the proxy department. It filed its own annual-meeting documents, and so did its newly birthed spinoff AbbVie. Not surprisingly, Abbott Chairman and CEO Miles White once again collected more than $25 million in compensation for the year.

Abbott's CEO paycheck bigger than its tax bill, study says

Some companies pay their CEOs more than they pay in U.S. taxes. That's the somewhat sensational conclusion of a study from the Institute for Policy Studies, a Washington, D.C. think tank. And among them, the IPS says, is Abbott Laboratories' CEO Miles White, a perennial top earner among Big Pharma executives.

Abbott opens the books on pharma spinoff

Pharma breakup followers, take note: Abbott Laboratories ($ABT) has unveiled its first-draft documents for the AbbVie spinoff. In a letter to shareholders filed with the Securities and Exchange Commission, Abbott discloses its management team, sets forth pro forma financials, and runs down the trends on product sales.

How does pharma's CEO pay rank?

We know how pharma CEO pay stacked up within the industry. But how did pharma's 2011 compensation packages compare with those in other industries?

Abbott touts positive Parkinson's Phase III as pharma split looms

Banking on double-digit earnings growth and a string of pipeline deals and developments, Abbott Laboratories execs said they are "on track" to go ahead and spin off the pharma side of the business later this year.

Abbott's White saw compensation drop in 2011

Abbott Laboratories ($ABT) had a memorable 2011 capped off by announcing that it would split into two companies: a pharma business and a medical products company. CEO Miles White (pictured), who will continue to lead the diversified medical products company, saw his total compensation fall slightly in 2011, coming in at just above $24 million. That's down about 6% from $25.6 million a year earlier.

Abbott's White sees bonus, stock awards slip

Abbott Laboratories Chairman and CEO Miles White (photo) received a 2 percent raise last year, to $1.89 million. However, his bonus and other stock awards dipped, according to an SEC filing. White

Abbott CEO says diversification delivers

Miles White (photo) has been CEO of Abbott Laboratories (NYSE: ABT) for 12 years, longer than any other current Big Pharma chief. And over those 12 years, he's done well by investors; the stock is up

Prosecutors win access to Abbott chief's email

Federal prosecutors want to read Miles White's inbox. And a U.S. judge has ordered the Abbott Laboratories CEO to hand over some of his email messages as part of a federal investigation into whether